Wellbutrin XL News
Drug wholesale prices up over 7% in 2007 - Medical Marketing and Media
GlaxoSmithKline raised the price of its antidepressant Wellbutrin XL by 44.5% from 2005 to 2007. Sanofi Aventis raised the price of its sleep drug Ambien ...
UPDATE 1-Watson posts fourth-quarter profit above estimates - Reuters
Watson's newer generic launches include versions of the popular antidepressant Wellbutrin XL, the fentanyl pain patch and an the oral contraceptive ...
The Wall Street Journal - Mediapost.com
GlaxoSmithKline raised the price of antidepressant Wellbutrin XL by 44.5% from 2005 to 2007. Sanofi-Aventis raised the price of sleep drug Ambien 70.1%. ...
UPDATE 1-Watson posts fourth-quarter profit above estimates - Reuters
Watson's newer generic launches include versions of the popular antidepressant Wellbutrin XL, the fentanyl pain patch and an the oral contraceptive ...
CORRECT: Biovail gets Canadian approval for new indication of ... - CNNMoney.com
Wellbutrin XL is already indicated for the treatment of depression in adults. US-listed shares of Biovail were up 5 cents at $14. ...
Biovail Gets Canadian Approval For Wellbutrin XL For The ... - RTT News
The efficacy of Wellbutrin XL for the prevention of seasonal major depressive episodes was established in three, double blind, placebo-controlled trials in ...
Canada OKs Wellbutrin for seasonal depression - Financial Post
Biovail Corp. said on Friday that Canadian health regulators have approved the use of its Wellbutrin XL anti-depressant for the treatment of seasonal ...
CORRECT: Biovail gets Canadian approval for new indication of ... - Trading Markets (press release)
Wellbutrin XL is already indicated for the treatment of depression in adults. US-listed shares of Biovail were up 5 cents at $14. Katherine Hunt kh/vj/kh.
(2ยบ) Prevention of Seasonal Major Depressive Illness - InfoBolsa
Wellbutrin(R) XL was commercialized in Canada in April 2006 by BPC. Biovail developed the formulation for Wellbutrin XL(R) and, in October 2001, ...
Biovail Gets Canadian Approval For Wellbutrin XL For Prevention Of ... - Trading Markets (press release)
The approval of Wellbutrin XL in seasonal major depressive illness represents Biovail's third Notice of Compliance in the past six months.
Wellbutrin XL RSS Feed